Top 10 Medical AI Companies to Buy According to Analysts
In this article, we will discuss the Top 10 Medical AI Companies to Buy According to Analysts.
Castle Biosciences Inc (CSTL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 647,391 | $23,001,802 | 0.17% | |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 100,332 | $3,564,796 | 0% | |
| 3. | Royce & Associates Chuck Royce | 59,513 | $2,114,497 | 0.02% | |
| 4. | Winton Capital Management David Harding | 24,741 | $879,048 | 0.03% | |
| 5. | AIGH Investment Partners Orin Hirschman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.27 | 2,500 | $43,175.00 | 9,065 | 2023-06-05 | Filing | |
| $11.23 | 2,300 | $25,829.00 | 6,565 | 2023-06-05 | Filing | |
| $21.50 | 1,162 | $24,983.00 | 2,968 | 2022-11-29 | Filing | |
| $18.77 | 220 | $4,129.40 | 1,806 | 2022-05-12 | Filing | |
| $18.76 | 1,100 | $20,636.00 | 1,586 | 2022-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.81 | 325 | $11,964.55 | 1,396 | 2026-11-02 | Filing | |
| $36.81 | 382 | $14,062.95 | 1,642 | 2026-11-02 | Filing | |
| $36.81 | 1,025 | $37,734.35 | 3,904 | 2026-11-02 | Filing | |
| $36.01 | 2,393 | $86,159.97 | 1,721 | 2026-11-02 | Filing | |
| $36.01 | 2,816 | $101,390.08 | 2,024 | 2026-11-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,500,897 | $53,326,870 | 0.03% | |
| 2. | 793,904 | $28,213,299 | 0% | |
| 3. | 692,104 | $24,588,715 | 0% | |
| 4. | 568,440 | $20,196,673 | 0.02% | |
| 5. | 369,641 | $13,133,345 | 0.02% |
News See All
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript May 6, 2026Castle Biosciences, Inc. reports earnings inline with expectations.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript February 26, 2026Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.23.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2025 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2025 Earnings Call Transcript November 3, 2025Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.34.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call Transcript August 4, 2025Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $-0.51.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Good afternoon and welcome to Castle Biosciences First Quarter 2025 Conference Call.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2024 Earnings Call Transcript February 27, 2025Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.3175, expectations were $-0.04.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2024 Earnings Call Transcript November 4, 2024Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $-0.06.
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript August 5, 2024Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.3104, expectations were $-0.16.
Hedge Fund Resource Center